Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of Tregs as a cell-based therapy via CD39 for benign prostate hyperplasia with inflammation.

Journal of cellular and molecular medicine - 1 May 2020

Jin Xi, Lin Tianhai, Yang Guang, Cai Huawei, Tang Bo, Liao Xinyang, Li Huifang, Chen Xiaoting, Gong Lina, Xu Hang, Sun Yi, Tan Ping, Yin Jianqiong, Ma Hongwen, Ai Jianzhong, Wang Kunjie, Wei Qiang, Yang Lu, Li Hong

Abstract excerpt

Benign prostatic hyperplasia (BPH) occurs most commonly among older men, often accompanied by chronic tissue inflammation. Although its aetiology remains unclear, autoimmune dysregulation may contribute to BPH. Regulatory T cells (Tregs) prevent autoimmune responses and maintain immune homeostasis. In this study, we aimed to investigate Tregs frequency, phenotype, and function in BPH patients and to evaluate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adoptive Transfer
Share to Apyrase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Autoimmunity

Share to Immunotherapy

Share to Inflammation

Share to Prostate

Share to Prostatic Hyperplasia

Share to T-Lymphocytes, Regulatory

Source

Open in PubMed Open full text

Identifiers

PMID: 32191396
DOI: 10.1111/jcmm.15137
PMCID: PMC7205803

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of Tregs as a cell-based therapy via CD39 for benign prostate hyperplasia with inflammation.PMID 32191396Read ↗

Immune dysregulation in the prostates of C57BL/6 <sup>Aire-/-</sup> mice mirrors that seen in human benign prostatic hyperplasiaSemantic proximity Read ↗

Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation.Semantic proximity Read ↗

Comparative RNA-sequencing analysis of the prostate in a mouse model of benign prostatic hyperplasia with bladder outlet obstructionSemantic proximity Read ↗

RNA sequencing and integrative analysis reveal pathways and hub genes associated with TGFβ1 stimulation on prostatic stromal cellsSemantic proximity Read ↗

Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasiaSemantic proximity Read ↗

TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO.Semantic proximity Read ↗

Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.Semantic proximity Read ↗

Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasiaSemantic proximity Read ↗

Inflammation Impacts Androgen Receptor Signaling in Basal Prostate Stem Cells Through Interleukin 1 Receptor AntagonistSemantic proximity Read ↗

CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.Semantic proximity Read ↗

Association of LTβR gene polymorphisms with prostate volume in benign prostatic hyperplasia in the Korean population.Semantic proximity Read ↗

Ixeris polycephala extract alleviates progression of benign prostatic hyperplasia in ratsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.